Wedbush Lifts Elevation Oncology's Price Target to $6 From $4 on 'Impressive' Data, Keeps Outperform Rating
Wedbush Lifts Elevation Oncology's Price Target to $6 From $4 on 'Impressive' Data, Keeps Outperform Rating
由於 “令人印象深刻” 的數據，Wedbush 將Elevation Oncology的目標股價從4美元上調至6美元，保持跑贏大盤評
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊